Drug Profile
Ciclosporin topical gel - Perioc
Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Perioc
- Class Anti-inflammatories; Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Heart failure therapies; Neuroprotectants
- Mechanism of Action Cyclophilin inhibitors; Peptidylprolyl isomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Periodontitis
Most Recent Events
- 06 Sep 2017 Phase-II development is ongoing in Sweden (EudraCT2014-002625-35)
- 01 Oct 2016 Perioc completes a phase II trial in Periodontitis (Adjunctive treatment) in Sweden (Topical)
- 26 Jan 2015 Phase-II clinical trials in Periodontitis (Adjunctive treatment) in Sweden (Topical)